Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,872
Closed -$277K 492
2025
Q3
$277K Sell
5,872
-1,428
-20% -$68.9K 0.02% 520
2025
Q2
$353K Sell
7,300
-3,142
-30% -$161K 0.02% 516
2025
Q1
$579K Buy
10,442
+1,629
+18% +$88.2K 0.03% 389
2024
Q4
$425K Sell
8,813
-127
-1% -$6.46K 0.03% 470
2024
Q3
$515K Buy
8,940
+1,296
+17% +$70K 0.03% 435
2024
Q2
$371K Buy
7,644
+2,017
+36% +$97.3K 0.02% 526
2024
Q1
$273K Sell
5,627
-2,173
-28% -$106K 0.02% 605
2023
Q4
$388K Buy
7,800
+3,039
+64% +$149K 0.03% 469
2023
Q3
$255K Buy
4,761
+655
+16% +$34.9K 0.02% 547
2023
Q2
$221K Buy
+4,106
New +$221K 0.02% 599
2015
Q4
Sell
-22,626
Closed -$1.07M 456
2015
Q3
$1.07M Sell
22,626
-1,704
-7% -$86.8K 0.14% 121
2015
Q2
$1.21M Buy
24,330
+11,493
+90% +$582K 0.14% 128
2015
Q1
$634K Buy
12,837
+6,484
+102% +$310K 0.07% 211
2014
Q4
$289K Sell
6,353
-24,848
-80% -$1.21M 0.03% 376
2014
Q3
$1.76M Buy
31,201
+10,555
+51% +$567K 0.2% 96
2014
Q2
$1.1M Sell
20,646
-457
-2% -$24.3K 0.12% 141
2014
Q1
$1.1M Buy
+21,103
New +$1.07M 0.12% 138
2013
Q3
Sell
-15,670
Closed -$807K 464
2013
Q2
$807K Buy
+15,670
New +$835K 0.11% 177

Other funds holding SNY

Pitcairn's SNY Position: Q4 2025 in Review

Pitcairn sold out of Sanofi (SNY) in Q4 2025, closing a stake of 5,872 shares — an estimated $277K sold.

Pitcairn first reported a position in SNY in Q2 2013 and held it in 18 quarters. The position peaked at $1.76M in Q3 2014. 754 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Pitcairn reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 5,872 Sanofi shares in Q4 2025, an estimated $277K.
  • Pitcairn first reported a position in Sanofi in Q2 2013 and held it in 18 quarters.
  • Pitcairn's Sanofi position peaked at $1.76M in Q3 2014.
  • 754 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.